Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 3/2012

Ausgabe 3/2012

Inhaltsverzeichnis ( 20 Artikel )

01.09.2012 | editorial | Ausgabe 3/2012

ASH 2011: “Real generosity toward the future lies in giving all to the present”

Michael Steurer M.D.

01.09.2012 | editorial | Ausgabe 3/2012

News from the Neuro-Oncology front

Silvia Hofer MD, Christine Marosi MD

01.09.2012 | special report | Ausgabe 3/2012

ASH 2011—Hodgkin’s disease and the high grade lymphomas

Wolfgang Willenbacher MD, Ella Willenbacher MD

01.09.2012 | short review | Ausgabe 3/2012

Treating T-cell lymphoma: is there a light at the end of the tunnel?

Georg Hopfinger, Olaf Merkel, Thomas Melchardt, Richard Greil

01.09.2012 | short review | Ausgabe 3/2012

ASH update 2011: chronic lymphocytic leukemia and indolent lymphoma

Michael Steurer MD

01.09.2012 | short review | Ausgabe 3/2012

Brief update on recent developments in CML

Stefan Schmidt MD

01.09.2012 | short review | Ausgabe 3/2012

New developments in MDS

Michael Pfeilstöcker MD, MBA, Reinhard Stauder MD, MSc

01.09.2012 | short review | Ausgabe 3/2012

ASH 2011—current developments in AML

Johannes Clausen M.D.

01.09.2012 | short review | Ausgabe 3/2012

Primary central nervous system lymphoma: update and current approach

Lauren E. Abrey M.D.

01.09.2012 | short review | Ausgabe 3/2012

Paraneoplastic neurologic disorders: a brief overview

Myrna R. Rosenfeld MD, PhD, Josep Dalmau MD, PhD

01.09.2012 | short review | Ausgabe 3/2012

Clinically useful biomarkers in neurooncology

Matthias Preusser MD

01.09.2012 | short review | Ausgabe 3/2012

Carcinomatous meningitis

Marc C. Chamberlain MD

01.09.2012 | short review | Ausgabe 3/2012

Advanced neuroimaging techniques for diagnosis and treatment evaluation in neuro-oncology

Bernhard Schuknecht MD, Krisztina Baráth MD, Silvia Hofer MD

01.09.2012 | short review | Ausgabe 3/2012

Drug therapy for recurrent, progressive, atypical, and malignant meningiomas

Prof. Christine Marosi M.D.

01.09.2012 | review | Ausgabe 3/2012 Open Access

Current treatment of low grade gliomas

Martin J. van den Bent MD, Tom J. Snijders MD, Jacoline E. C. Bromberg MD

01.09.2012 | short review | Ausgabe 3/2012 Open Access

Update on molecular and genetic alterations in adult medulloblastoma

Marcel Kool PhD, Andrey Korshunov MD, Stefan M. Pfister MD

01.09.2012 | short review | Ausgabe 3/2012

The End-of-Life in patients with glioma and their families

Christine Marosi MD, Birgit Flechl, Stefan Oberndorfer

01.09.2012 | short review | Ausgabe 3/2012

New drugs for head and neck cancer

József Dudás PhD, Heinz Zwierzina MD, Dr. Georg Mathias Sprinzl MD

01.09.2012 | short review | Ausgabe 3/2012

Follow-up care for head and neck cancer patients

Markus Hambek MD

01.09.2012 | case report | Ausgabe 3/2012

Sorafenib in thyroid cancer—a retrospective case series

Gabriele Gamerith MD, Andreas Pircher MD, Arno Amann MD, Katharina Cima MD, Klaus Gasser MD, Markus Lenzhofer MD, Peter Lind MD, Evelyne Bareck MD, Ewald Wöll MD, Wolfgang Hilbe MD

Aktuelle Ausgaben